Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
A "lost" Beatles record that was found after being missing for more than 50 years has sold for £18,000 at auction.
Police have confirmed a 26-year-old man from Cornwall has died at the campsite area of the Cheshire festival.
Downpours keeping us on our toes today